Filing Details
- Accession Number:
- 0000899243-19-004555
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-22 16:16:59
- Reporting Period:
- 2019-02-21
- Accepted Time:
- 2019-02-22 16:16:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
31791 | Perkinelmer Inc | PKI | Laboratory Analytical Instruments (3826) | 042052042 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1044005 | P Alexis Michas | 940 Winter Street Waltham MA 02451 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-02-21 | 7,071 | $27.79 | 59,917 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-02-21 | 2,118 | $92.96 | 57,799 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | NQ Stock Option(right to buy) | Disposition | 2019-02-21 | 7,071 | $0.00 | 7,071 | $27.79 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2019-05-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 500 | Indirect | By spouse IRA |
Footnotes
- Includes shares related to dividends on shares in the Reporting Person's Deferred Compensation Plan account.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $92.944 to $92.982. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- This option became exercisable in three equal annual installments beginning on May 1, 2013, which was the first anniversary of the date on which the option was granted.